中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2015年
10期
24-25,26
,共3页
汽化电切术%吡柔比星%浅表性膀胱癌%临床疗效
汽化電切術%吡柔比星%淺錶性膀胱癌%臨床療效
기화전절술%필유비성%천표성방광암%림상료효
Transurethral resection%Pirarubicin%Superficial bladder cancer%Clinical effect
目的：分析汽化电切术联合吡柔比星膀胱灌注化疗在治疗浅表性膀胱癌中的临床疗效。方法：选取本院2010年6月-2012年6月收治的72例膀胱癌患者，按照随机数字表法，将患者分为试验组与对照组，每组各36例患者。其中，试验组采取汽化电切术联合吡柔比星膀胱灌注化疗，对照组仅行汽化电切术治疗，观察两组患者短期疗效并进行随访1年。结果：试验组患者术后留置导尿管时间（3.7±0.5）d，对照组患者术后留置导尿管时间（6.3±0.7）d，两组比较差异有统计学意义（P<0.05）；试验组术后1年内出现肿瘤复发患者6例，对照组复发12例，两组患者肿瘤复发率比较差异具有统计学意义（P<0.05）；随访1年试验组患者对治疗满意率为58.3%，高于对照组36.1%，两组比较差异有统计学意义（P<0.05）。结论：汽化电切术联合吡柔比星膀胱灌注化疗对于浅表性膀胱癌的治疗效果较好，明显降低患者短期复发率，提高了患者对治疗满意度，值得在临床应用。
目的：分析汽化電切術聯閤吡柔比星膀胱灌註化療在治療淺錶性膀胱癌中的臨床療效。方法：選取本院2010年6月-2012年6月收治的72例膀胱癌患者，按照隨機數字錶法，將患者分為試驗組與對照組，每組各36例患者。其中，試驗組採取汽化電切術聯閤吡柔比星膀胱灌註化療，對照組僅行汽化電切術治療，觀察兩組患者短期療效併進行隨訪1年。結果：試驗組患者術後留置導尿管時間（3.7±0.5）d，對照組患者術後留置導尿管時間（6.3±0.7）d，兩組比較差異有統計學意義（P<0.05）；試驗組術後1年內齣現腫瘤複髮患者6例，對照組複髮12例，兩組患者腫瘤複髮率比較差異具有統計學意義（P<0.05）；隨訪1年試驗組患者對治療滿意率為58.3%，高于對照組36.1%，兩組比較差異有統計學意義（P<0.05）。結論：汽化電切術聯閤吡柔比星膀胱灌註化療對于淺錶性膀胱癌的治療效果較好，明顯降低患者短期複髮率，提高瞭患者對治療滿意度，值得在臨床應用。
목적：분석기화전절술연합필유비성방광관주화료재치료천표성방광암중적림상료효。방법：선취본원2010년6월-2012년6월수치적72례방광암환자，안조수궤수자표법，장환자분위시험조여대조조，매조각36례환자。기중，시험조채취기화전절술연합필유비성방광관주화료，대조조부행기화전절술치료，관찰량조환자단기료효병진행수방1년。결과：시험조환자술후류치도뇨관시간（3.7±0.5）d，대조조환자술후류치도뇨관시간（6.3±0.7）d，량조비교차이유통계학의의（P<0.05）；시험조술후1년내출현종류복발환자6례，대조조복발12례，량조환자종류복발솔비교차이구유통계학의의（P<0.05）；수방1년시험조환자대치료만의솔위58.3%，고우대조조36.1%，량조비교차이유통계학의의（P<0.05）。결론：기화전절술연합필유비성방광관주화료대우천표성방광암적치료효과교호，명현강저환자단기복발솔，제고료환자대치료만의도，치득재림상응용。
Objective:To analyze the clinical curative of transurethral resection combined with pirarubicin intravesical chemotherapy in the treatment of superficial bladder cancer.Method:72 cases patients from June 2010 to June 2012 were selected and analyzed.With the random number table, the patients were divided into experimental group and control group,36 cases in each group.The experimental group was treated the transurethral resection combined with pirarubicin intravesical chemotherapy,the control group was treated with transurethral resection.The short-term efficacy of two groups were observed and followed up for 1 year.Result:The catheter indwelling time of experimental group patients were(3.7±0.5) d,which in control group patients were(6.3±0.7)d,the difference was statistically significant(P<0.05);after operation one year, the experiment group 6 patients occurred tumor recurrence,12 cases of control group relapsed,compared two groups of patients tumor recurrence rate ,the difference has statistically significant (P<0.05).Conclusion:Electrovaporization combined with bladder instillation in treatment of superficial bladder cancer is better in effect.The patients’ short-term recurrence rate are significantly lower, and the patients’treatment satisfaction improve, it is worth in the clinical application.
